Illumina & Donald Trump

Illumina: Illumina seeks to rebuild its business after Beijing lifted an export ban, but remains on China's 'unreliable entity' list due to U.S.-China tensions over biotech security.

Donald Trump: Donald Trump is leading the U.S. business delegation to a summit with Xi Jinping to resolve business issues between the two nations.

Illumina: Illumina, a joint venture between LONGi and Invenergy, has reduced LONGi's ownership stake but remains uncertain about its future.

Donald Trump: Donald Trump's administration policies are driving the uncertainty in the U.S. solar industry by restricting Chinese companies' access to clean-energy subsidies.

Illumina: Illumina's Jacob Thaysen is attending the summit as part of the US business delegation.

Donald Trump: Donald Trump, the US President, is leading the delegation to China to strengthen economic ties, extend a trade truce, and secure business deals, particularly in aviation, agriculture, and energy.

Illumina: Illumina's CEO, Jacob Thaysen, is part of the delegation, representing the biotechnology and genomics industry's interests in U.S.-China trade.

Donald Trump: Donald Trump, as the President of the United States, is leading the delegation to China to discuss trade, artificial intelligence, and other issues with Xi Jinping. His administration's trade policies have significantly impacted companies like Apple Inc. and Boeing.

Illumina: Illumina's CEO, Jacob Thaysen, was invited to join Donald Trump's trip to China, suggesting biotech sector interest.

Donald Trump: As the President of the United States, Donald Trump is visiting China for a summit with Xi Jinping to discuss trade, Taiwan, and other geopolitical issues.

Illumina: Illumina's CEO, Jacob_Thaysen, was invited to join Donald Trump on his trip to China.

Donald Trump: Donald Trump arrived in Beijing for a summit with Xi Jinping to discuss trade, the war with Iran, and arms sales to Taiwan. His administration is also dealing with domestic issues like inflation, immigration, and healthcare fraud.